COVID-19 Information

Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Title(s):
Interim Director and Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations:
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute

Department(s):
The Dartmouth Institute
Medicine
Community and Family Medicine

Education:
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Programs:
Norris Cotton Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice

Contact Information:

Dartmouth Medical School
HB 7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-653-3568
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-653-0802
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU


Professional Interests:

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information:

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught:

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis


Selected Publications:

 

Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield.
Onega T, Zhu W, Kerlikowske K, Miglioretti DL, Lee CI, Henderson LM, Tosteson ANA, Wernli KJ, diFlorio R, Weaver DL, Buist DSM
Breast Cancer Res Treat. 2021 Oct 22; doi: 10.1007/s10549-021-06418-x. Epub 2021 Oct 22.
PMID: 34686934

Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
Lowry KP, Bissell M, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EJA, Buist DSM, Tosteson ANA, Henderson L, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL
Radiology. 2021 Oct 19;:211808. doi: 10.1148/radiol.2021211808. Epub 2021 Oct 19.
PMID: 34665032

Reply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEF.
Gilstrap L, Austin AM, Gladders B, Goyal P, O'Malley J, Barnato A, Tosteson ANA, Skinner JS
J Am Geriatr Soc. 2021 Oct 9; doi: 10.1111/jgs.17488. Epub 2021 Oct 9.
PMID: 34626425

Incorporating broadband durability in measuring geographic access to health care in the era of telehealth: A case example of the 2-step virtual catchment area (2SVCA) Method.
Alford-Teaster J, Wang F, Tosteson ANA, Onega T
J Am Med Inform Assoc. 2021 Oct 12;28(11):2526-2530. doi: 10.1093/jamia/ocab149.
PMID: 34414437

Multilevel follow-up of cancer screening (mFOCUS): Protocol for a multilevel intervention to improve the follow-up of abnormal cancer screening test results.
Haas JS, Atlas SJ, Wright A, Orav EJ, Aman DG, Breslau ES, Burdick TE, Carpenter E, Chang F, Dang T, Diamond CJ, Feldman S, Harris KA, Hort SJ, Housman ML, Mecker A, Lehman CD, Percac-Lima S, Smith R, Wint AJ, Yang J, Zhou L, Tosteson ANA
Contemp Clin Trials. 2021 Aug 8;109:106533. doi: 10.1016/j.cct.2021.106533. Epub 2021 Aug 8.
PMID: 34375748

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H, Lee SJ, Schechter CB, Tosteson ANA, Miglioretti DL, Trentham-Dietz A, Nyante SJ, Kerlikowske K, Sprague BL, Stout NK
J Natl Cancer Inst. 2021 Jul 14; pii: djab097. doi: 10.1093/jnci/djab097. Epub 2021 Jul 14.
PMID: 34258611

Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.
Sprague BL, O'Meara ES, Lee CI, Lee JM, Henderson LM, Buist DSM, Alsheik N, Macarol T, Perry H, Tosteson ANA, Onega T, Kerlikowske K, Miglioretti DL
Prev Med. 2021 Oct;151:106540. doi: 10.1016/j.ypmed.2021.106540. Epub 2021 Jun 30.
PMID: 34217424

Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.
Schifferdecker KE, Vaclavik D, Wernli KJ, Buist DSM, Kerlikowske K, Sprague BL, Henderson LM, Johnson D, Budesky J, Jackson-Nefertiti G, Miglioretti DL, Tosteson ANA
Prev Med. 2021 Oct;151:106542. doi: 10.1016/j.ypmed.2021.106542. Epub 2021 Jun 30.
PMID: 34217409

The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction.
Gilstrap L, Austin AM, Gladders B, Goyal P, O'Malley AJ, Barnato A, Tosteson ANA, Skinner JS
J Am Geriatr Soc. 2021 Oct;69(10):2811-2820. doi: 10.1111/jgs.17310. Epub 2021 Jun 15.
PMID: 34129234

Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
Tosteson ANA, Tapp S, Titus LJ, Nelson HD, Longton GM, Bronson M, Pepe M, Carney PA, Onega T, Piepkorn MW, Knezevich SR, Barnhill R, Weinstock MA, Elder DE, Elmore JG
JAMA Dermatol. 2021 Sep 1;157(9):1102-1106. doi: 10.1001/jamadermatol.2021.1779.
PMID: 34076664

View more publications on PubMed